Home > Health > Herpes simplex virus infections Therapeutic Pipeline Analysis

Herpes simplex virus infections Therapeutic Pipeline Analysis

Added: (Fri Dec 07 2018)

Pressbox (Press Release) - The study analysed that the Herpes simplex virus infections pipeline comprises of 20 drug candidates in different stages of development.

Browse report sample at: https://www.psmarketresearch.com/market-analysis/hsv-infections-therapeutics-pipeline-analysis/report-sample

Many technologies are being developed that offer promising innovative treatments which can control the progression of Herpes simplex virus infections. The technologies include, but not limited to, Vector based technology platform, AdenoVerse technology platform, Juvariís technology platform and Nanostat technology platform.

The research found that various companies have collaborated for the development of Herpes simplex virus infections pipeline. In June 2014, PaxVax Inc., entered into a research and development collaboration with the University of California to develop a combination vaccine to prevent genital herpes simplex virus infections.

Browse report at: https://www.psmarketresearch.com/market-analysis/hsv-infections-therapeutics-pipeline-analysis

Some of the key players developing drugs for the treatment of Herpes virus simplex infections include Maruho Co., Ltd., NanoBio Corporation, Lumavita AG and others.

Submitted by:Vijay
Disclaimer: Pressbox disclaims any inaccuracies in the content contained in these releases. If you would like a release removed please send an email to remove@pressbox.com together with the url of the release.